MedInfo World

Empowering patients through shared knowledge and community-driven health insights.

Platform

Drug Information
Health Conditions
Active Ingredients

Support

Help Center
Terms of Use
Privacy Policy
Disclaimer

Company

About Us
Contact

Medical Disclaimer

The information on this website is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Terms Privacy Disclaimer

Sparsentan – Uses, Side Effects, Dosage & Drug Information | MedInfo World | MedInfo World

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.

Home Active IngredientsSparsentan

Sparsentan

Endothelin Receptor Antagonist [EPC]

1 Drug2 Variants

Clinical Data

Name

Sparsentan

Raw Name

SPARSENTAN

Drug Classes

Endothelin Receptor Antagonist [EPC]Angiotensin 2 Receptor Blocker [EPC]

Important Notice

This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Sparsentan.

Mechanism of Action

Endothelin Receptor Antagonists [MoA]Angiotensin 2 Type 1 Receptor Antagonists [MoA]Cytochrome P450 2B6 Inducers [MoA]Cytochrome P450 2C9 Inducers [MoA]Cytochrome P450 2C19 Inducers [MoA]P-Glycoprotein Inhibitors [MoA]Breast Cancer Resistance Protein Inhibitors [MoA]

Identifiers

RxCUI

2630540, 2630546, 2630548, 2630550

UNII

9242RO5URM

Drugs with Sparsentan

Medications containing this ingredient

Filspari